An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Akili to Participate in the Cowen 43rd Annual Health Care Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Akili, Inc. (Nasdaq: AKLI), a pioneer in digital medicine, will participate in the Cowen 43rd Annual Health Care Conference in Boston on March 8. Highlights include a panel discussion with Scott Kollins, Chief Medical Officer, at 8 AM on prescription digital therapeutics and a 9:50 AM fireside chat featuring Co-Founder and CEO Eddie Martucci along with President Matt Franklin. The company will engage with investors throughout the day. Akili is noted for its innovative treatments targeting cognitive impairments through engaging video game experiences, supported by rigorous clinical research.
Positive
None.
Negative
None.
BOSTON--(BUSINESS WIRE)--
Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will participate in the Cowen 43rd Annual Health Care Conference in Boston next month.
On March 8, Akili sessions are scheduled for the following times:
8am: Scott Kollins, Akili Chief Medical Officer, will represent the company on a panel discussion about prescription digital therapeutics (PDTs) and how PDTs can aid in overall care and outcomes.
9:50 am: Fireside Chat with Eddie Martucci, Akili Co-Founder and Chief Executive Officer & Matt Franklin, President and Chief Operating Officer
Company leaders will also meet with investors throughout the day on March 8.
About Akili
Akili is pioneering the development of cognitive treatments through game-changing technologies. Akili’s approach of leveraging technologies designed to directly target the brain establishes a new category of medicine – medicine that is validated through clinical trials like a drug or medical device but experienced like entertainment. Akili’s platform is powered by proprietary therapeutic engines designed to target cognitive impairment at its source in the brain, informed by decades of research and validated through rigorous clinical programs. Driven by Akili’s belief that effective medicine can also be fun and engaging, Akili’s products are delivered through captivating action video game experiences. For more information, please visit www.akiliinteractive.com.